Daniel Teper
Seminars
Thursday 23rd July 2026
Scaling Astatine-211 Supply: Overcoming the Manufacturing Challenges Limiting Clinical Adoption
1:30 pm
- Evaluating the infrastructure, production and distribution requirements needed to enable reliable Astatine-211 supply
- Addressing the manufacturing and logistical bottlenecks restricting broader clinical development and multi-site trial execution
- Developing scalable supply strategies to support the future commercialisation of Astatine-211 radiopharmaceuticals
